News

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...
A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...
The House Judiciary Committee subpoenaed a former Pfizer Inc. executive, demanding he address allegations of deliberately ...
Pfizer's recent trial termination makes it yet another company facing challenges with CD47 studies in oncology.
Chairman Jim Jordan subpoenaed former Pfizer executive Dr. Philip Dormitzer for an investigation into delayed COVID-19 ...
House Judiciary Chair Jim Jordan subpoenaed Dr. Philip Dormitzer after he refused to testify in the 2020 vaccine delay probe, ...
Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...
Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...
Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...
Pfizer's hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain types of antibodies, ...
(Reuters) -The U.S. House Judiciary Committee on Monday subpoenaed a former Pfizer executive after he declined to voluntarily ...